SLC29A4
Basic information
Region (hg38): 7:5274369-5306912
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC29A4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 66 | 72 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 67 | 7 | 5 |
Variants in SLC29A4
This is a list of pathogenic ClinVar variants found in the SLC29A4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-5287856-G-A | not specified | Uncertain significance (Feb 11, 2025) | ||
7-5287886-A-C | Benign (Dec 31, 2019) | |||
7-5287900-C-T | SLC29A4-related disorder | Likely benign (Jul 01, 2019) | ||
7-5287901-G-A | not specified | Uncertain significance (Dec 20, 2023) | ||
7-5287902-A-G | SLC29A4-related disorder | Benign (Feb 21, 2019) | ||
7-5287923-C-T | not specified | Uncertain significance (Nov 14, 2024) | ||
7-5287926-C-T | not specified | Uncertain significance (Jun 07, 2024) | ||
7-5287927-G-A | SLC29A4-related disorder | Likely benign (Nov 21, 2019) | ||
7-5287928-G-GAGGCGGCTC | Uncertain significance (Nov 27, 2017) | |||
7-5287932-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
7-5287959-G-T | not specified | Uncertain significance (Jan 17, 2025) | ||
7-5287970-G-C | not specified | Uncertain significance (Oct 16, 2024) | ||
7-5290737-G-A | not specified | Uncertain significance (Sep 09, 2021) | ||
7-5290752-G-A | not specified | Uncertain significance (Jan 09, 2025) | ||
7-5290780-C-T | not specified | Uncertain significance (May 22, 2023) | ||
7-5290792-C-A | not specified | Uncertain significance (Aug 04, 2023) | ||
7-5290797-G-A | not specified | Uncertain significance (Feb 24, 2022) | ||
7-5291127-C-T | not specified | Uncertain significance (Jun 07, 2023) | ||
7-5291141-G-A | not specified | Uncertain significance (Jun 26, 2024) | ||
7-5291183-C-G | not specified | Uncertain significance (Jun 10, 2024) | ||
7-5291183-C-T | not specified | Uncertain significance (Apr 19, 2023) | ||
7-5291195-G-A | not specified | Uncertain significance (Dec 23, 2024) | ||
7-5291233-C-G | SLC29A4-related disorder | Likely benign (Feb 01, 2023) | ||
7-5291716-C-T | not specified | Uncertain significance (Dec 14, 2023) | ||
7-5291725-A-G | not specified | Uncertain significance (Feb 01, 2025) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC29A4 | protein_coding | protein_coding | ENST00000396872 | 10 | 32502 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000114 | 0.951 | 125675 | 0 | 68 | 125743 | 0.000270 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.00 | 420 | 366 | 1.15 | 0.0000250 | 3392 |
Missense in Polyphen | 112 | 114.49 | 0.97825 | 1099 | ||
Synonymous | -7.15 | 292 | 172 | 1.69 | 0.0000134 | 1130 |
Loss of Function | 1.82 | 11 | 19.7 | 0.557 | 9.06e-7 | 219 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000180 | 0.000178 |
Ashkenazi Jewish | 0.000324 | 0.000298 |
East Asian | 0.000110 | 0.000109 |
Finnish | 0.000169 | 0.000139 |
European (Non-Finnish) | 0.000402 | 0.000387 |
Middle Eastern | 0.000110 | 0.000109 |
South Asian | 0.000262 | 0.000261 |
Other | 0.000517 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Functions as a polyspecific organic cation transporter, efficiently transporting many organic cations such as monoamine neurotransmitters 1-methyl-4-phenylpyridinium and biogenic amines including serotonin, dopamine, norepinephrine and epinephrine. May play a role in regulating central nervous system homeostasis of monoamine neurotransmitters. May be involved in luminal transport of organic cations in the kidney and seems to use luminal proton gradient to drive organic cation reabsorption. Does not seem to transport nucleoside and nucleoside analogs such as uridine, cytidine, thymidine, adenosine, inosine, guanosine, and azidothymidine. In (PubMed:16873718) adenosine is efficiently transported but in a fashion highly sensitive to extracellular pH, with maximal activity in the pH range 5.5 to 6.5. Glu-206 is essential for the cation selectivity and may function as the charge sensor for cationic substrates. Transport is chloride and sodium-independent but appears to be sensitive to changes in membrane potential. Weakly inhibited by the classical inhibitors of equilibrative nucleoside transport, dipyridamole, dilazep, and nitrobenzylthioinosine. May play a role in the regulation of extracellular adenosine concentrations in cardiac tissues, in particular during ischemia. {ECO:0000269|PubMed:15448143, ECO:0000269|PubMed:16873718, ECO:0000269|PubMed:17018840, ECO:0000269|PubMed:17121826}.;
- Pathway
- Metformin Pathway, Pharmacokinetics;Tyrosine metabolism;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of small molecules;Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane
(Consensus)
Recessive Scores
- pRec
- 0.130
Intolerance Scores
- loftool
- 0.566
- rvis_EVS
- -0.99
- rvis_percentile_EVS
- 8.64
Haploinsufficiency Scores
- pHI
- 0.225
- hipred
- N
- hipred_score
- 0.390
- ghis
- 0.446
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.254
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc29a4
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- monoamine transport;nucleoside transmembrane transport
- Cellular component
- plasma membrane;integral component of membrane;apical plasma membrane
- Molecular function
- nucleoside transmembrane transporter activity;monoamine transmembrane transporter activity